Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 136

1.

C-reactive protein and interleukin-18 levels in relation to coronary heart disease: prospective cohort study from Busselton Western Australia.

Hung J, Knuiman MW, Divitini ML, Langton PE, Chapman CL, Beilby JP.

Heart Lung Circ. 2008 Apr;17(2):90-5.

PMID:
17851127
2.

Increased concentrations of C-reactive protein and IL-6 but not IL-18 are independently associated with incident coronary events in middle-aged men and women: results from the MONICA/KORA Augsburg case-cohort study, 1984-2002.

Koenig W, Khuseyinova N, Baumert J, Thorand B, Loewel H, Chambless L, Meisinger C, Schneider A, Martin S, Kolb H, Herder C.

Arterioscler Thromb Vasc Biol. 2006 Dec;26(12):2745-51.

3.

C-reactive protein and coronary heart disease in western Turkey.

Onat A, Sansoy V, Yildirim B, Keleş I, Uysal O, Hergenç G.

Am J Cardiol. 2001 Sep 15;88(6):601-7.

PMID:
11564380
4.

Higher level of systemic C-reactive protein is independently predictive of coronary heart disease in older community-dwelling adults: the three-city study.

Straczek C, Ducimetiere P, Barberger-Gateau P, Helmer C, Ritchie K, Jouven X, Carcaillon L, Amouyel P, Tzourio C, Empana JP.

J Am Geriatr Soc. 2010 Jan;58(1):129-35. doi: 10.1111/j.1532-5415.2009.02625.x.

PMID:
20002508
5.

C-reactive protein and the 10-year incidence of coronary heart disease in older men and women: the cardiovascular health study.

Cushman M, Arnold AM, Psaty BM, Manolio TA, Kuller LH, Burke GL, Polak JF, Tracy RP.

Circulation. 2005 Jul 5;112(1):25-31.

6.

C-reactive protein and incident coronary heart disease in the Atherosclerosis Risk In Communities (ARIC) study.

Folsom AR, Aleksic N, Catellier D, Juneja HS, Wu KK.

Am Heart J. 2002 Aug;144(2):233-8.

PMID:
12177639
7.
8.

A comparison of the associations between seven hemostatic or inflammatory variables and coronary heart disease.

Woodward M, Rumley A, Welsh P, MacMahon S, Lowe G.

J Thromb Haemost. 2007 Sep;5(9):1795-800.

9.

High-sensitivity C-reactive protein and coronary heart disease in a general population of Japanese: the Hisayama study.

Arima H, Kubo M, Yonemoto K, Doi Y, Ninomiya T, Tanizaki Y, Hata J, Matsumura K, Iida M, Kiyohara Y.

Arterioscler Thromb Vasc Biol. 2008 Jul;28(7):1385-91. doi: 10.1161/ATVBAHA.107.157164.

11.

Interleukin-18 and the risk of coronary heart disease in European men: the Prospective Epidemiological Study of Myocardial Infarction (PRIME).

Blankenberg S, Luc G, Ducimetière P, Arveiler D, Ferrières J, Amouyel P, Evans A, Cambien F, Tiret L; PRIME Study Group..

Circulation. 2003 Nov 18;108(20):2453-9.

12.

C-reactive protein distribution and correlates among men and women with chronic coronary heart disease.

Benderly M, Haim M, Boyko V, Tanne D, Behar S, Matas Z, Zimlichman R, Goldbourt U.

Cardiology. 2007;107(4):345-53.

PMID:
17283424
13.

Effect of plasma C-reactive protein levels in modulating the risk of coronary heart disease associated with small, dense, low-density lipoproteins in men (The Quebec Cardiovascular Study).

St-Pierre AC, Bergeron J, Pirro M, Cantin B, Dagenais GR, Després JP, Lamarche B; Quebec Cardiovascular Study..

Am J Cardiol. 2003 Mar 1;91(5):555-8.

PMID:
12615259
15.

High-sensitivity C-reactive protein is quite low in Japanese men at high coronary risk.

Matsushita K, Yatsuya H, Tamakoshi K, Yang PO, Otsuka R, Wada K, Mitsuhashi H, Hotta Y, Kondo T, Murohara T, Toyoshima H.

Circ J. 2007 Jun;71(6):820-5.

16.
17.

C-reactive protein, interleukin-6, and fibrinogen as predictors of coronary heart disease: the PRIME Study.

Luc G, Bard JM, Juhan-Vague I, Ferrieres J, Evans A, Amouyel P, Arveiler D, Fruchart JC, Ducimetiere P; PRIME Study Group..

Arterioscler Thromb Vasc Biol. 2003 Jul 1;23(7):1255-61.

18.

C-reactive protein as a risk factor for coronary heart disease: a systematic review and meta-analyses for the U.S. Preventive Services Task Force.

Buckley DI, Fu R, Freeman M, Rogers K, Helfand M.

Ann Intern Med. 2009 Oct 6;151(7):483-95. Review.

PMID:
19805771
19.
20.

C-reactive protein and prediction of coronary heart disease and global vascular events in the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER).

Sattar N, Murray HM, McConnachie A, Blauw GJ, Bollen EL, Buckley BM, Cobbe SM, Ford I, Gaw A, Hyland M, Jukema JW, Kamper AM, Macfarlane PW, Murphy MB, Packard CJ, Perry IJ, Stott DJ, Sweeney BJ, Twomey C, Westendorp RG, Shepherd J; PROSPER Study Group..

Circulation. 2007 Feb 27;115(8):981-9.

Items per page

Supplemental Content

Support Center